Newsletter Archives | Page 6 of 13 | McDermott Newsletter Archives | Page 6 of 13 | McDermott

McDermott Will & Schulte, a global law firm

Keywords – Hidden: Newsletter

  • Healthcare Regulatory Check-Up Newsletter | December 2023 Recap

    Healthcare Regulatory Check-Up Newsletter | December 2023 Recap

    REPORT

    Healthcare Regulatory Check-Up Newsletter | December 2023 Recap

    January 2024

    Read time: 2 min

    Key takeaways
    Overview

    This issue of McDermott’s Healthcare Regulatory Check-Up highlights significant regulatory activity for December 2023. We discuss several civil and criminal enforcement actions that involve alleged violations of the False Claims Act (FCA) and the Anti-Kickback Statute (AKS). We also review a recent advisory opinion issued by the Office of the Inspector General (OIG) pertaining to a medical-device manufacturer’s proposal to subsidize certain Medicare cost-sharing obligations in the context of a clinical trial. Finally, we examine other notable healthcare regulatory and legislative updates.

    In depth
    Authors

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Monica Wallace

    Partner

    Chicago

    Jamie B. Gelfman

    Partner

    Miami

    Grayson I. Dimick

    Associate

    Washington, DC

    Chelsea Olivera

    Associate

    Miami

    More Insights

  • Healthcare Regulatory Check-Up Newsletter | November 2023 Recap

    Healthcare Regulatory Check-Up Newsletter | November 2023 Recap

    REPORT

    Healthcare Regulatory Check-Up Newsletter | November 2023 Recap

    December 2023

    Read time: 2 min

    Key takeaways
    Overview

    This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity for November 2023. We discuss several US Department of Health and Human Services (HHS) agency actions, including the new General Compliance Program Guidance (GCPG), revisions to the Designated Health Services Code List and to the Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Final Rule, changes to ownership disclosure requirements for skilled nursing facilities (SNFs) and nursing homes, and a No Surprises Act (NSA) consumer toolkit. We also discuss several criminal and civil enforcement actions that involve alleged violations of the False Claims Act (FCA) and the Anti-Kickback Statute (AKS).

    In depth
    Authors

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Monica Wallace

    Partner

    Chicago

    Nicholas F. Alarif

    Partner

    Washington, DC

    More Insights

  • International News: Spotlight on Foreign Investment

    International News: Spotlight on Foreign Investment

    INTERNATIONAL NEWS / REPORT

    International News: Spotlight on Foreign Investment

    December 2023

    Read time: 3 min

    Key takeaways
    Overview

    In this dynamic global landscape, investors have always been required to make savvy, smart choices. This requires navigating through the intricate web of bilateral treaty protection, exploring the vital role these agreements play in safeguarding investments across borders. An example lies in the Energy sector, as the Energy Charter Treaty shapes international investment strategies.

    In our latest issue of International News, we take a look across sectors and issues of concern to investors, exploring carve-outs and their strategic implications, a deep dive into the fascinating world of investing in sports—a realm where financial strategy meets passion and global markets converge. We focus on the burgeoning healthcare sector in Asia, analyzing the opportunities and challenges that come with investing in this rapidly evolving landscape. We address the pressing issues of currency volatility, anti-coercion measures, and the recently enacted Foreign Subsidies Regulation in the European Union. Together, these issues weave a rich tapestry of elements informing investment decisions in an ever-changing global economy.

    In depth
    Authors

    Greg C. Berson

    Partner

    Washington, DC

    Thomas P. Conaghan

    Partner

    Washington, DC, New York – One Vanderbilt Avenue

    Stéphane Dionnet

    Partner

    Brussels

    Vlad Maly

    Partner

    London – 22 Bishopsgate

    Stefano Mechelli

    Counsel

    Milan, New York – One Vanderbilt Avenue

    Sabine Naugès

    Partner

    Paris

    Lisa M. Richman

    Partner

    Washington, DC

    Sam Snider

    Partner

    Atlanta

    Andrew J. Warmus

    Partner

    Chicago

    More Insights

  • Healthcare Regulatory Check-up Newsletter | October 2023 Recap

    Healthcare Regulatory Check-up Newsletter | October 2023 Recap

    REPORT

    Healthcare Regulatory Check-up Newsletter | October 2023 Recap

    November 2023

    Read time: 2 min

    Key takeaways
    Overview

    This issue of McDermott’s Healthcare Regulatory Check-Up highlights significant regulatory activity for October 2023. We discuss several enforcement actions that involve violations of the False Claims Act (FCA) and the Anti-Kickback Statute (AKS). We also review recent Office of the Inspector General (OIG) advisory opinions on a proposed employment compensation bonus methodology and provision of free hearing aids to Medicare beneficiaries contingent on the sale of a Medicare-reimbursable cochlear implant.

    In depth
    Authors

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Monica Wallace

    Partner

    Chicago

    Kyle E. Hafkey

    Associate

    Boston

    Kelsey R. Reinhardt

    Associate

    Los Angeles

    More Insights

  • Cartel Corner | July 2023

    Cartel Corner | July 2023

    REPORT

    Cartel Corner | July 2023

    July 2023

    Read time: 3 min

    Key takeaways
    Overview

    In the first half of 2023, antitrust enforcers remained remarkably busy both in the United States (US) and across the European Union (EU). The US Department of Justice’s (DOJ’s) Antitrust Division (Division) and the Federal Trade Commission (FTC) have continued their aggressive and novel effort to drag antitrust enforcement into the labor markets. The DOJ Procurement Collusion Strike Force (PCSF) has pursued its crackdown on antitrust and fraud involving government procurement with a number of recent cases. And DOJ has pushed the boundaries under Section 2 of the Sherman Act—both by revitalizing the criminal provisions of the law and by pursuing “attempts” to monopolize criminally. The European Union has also kept the pressure on those doing business overseas, imposing significant fines in recent matters and upgrading its online leniency program to make it easier for companies to report wrongdoing.

    In this installment of Cartel Corner, we examine this continued aggressiveness toward antitrust enforcement. While these government enforcement efforts have not always been successful, they have nonetheless reframed the landscape for many companies and individuals. What was once thought of as a civil antitrust violation at worst—or no violation at all—is now often pursued criminally. And antitrust enforcers are speaking in more strident tones as they attempt to remake, in certain ways, the way companies do business in the United States and abroad.

    Whether antitrust enforcers are ultimately successful remains to be seen. Nonetheless, the trend is real, and it is one that all companies should be prepared to address in the weeks and months to come.

    In depth
    Authors

    Paul M. Thompson

    Partner

    Washington, DC

    Stéphane Dionnet

    Partner

    Brussels

    Graham J. Hyman

    Associate, Law Clerk

    New York – One Vanderbilt Avenue

    More Insights

  • International News: Spotlight on ESG, Impact & Sustainability

    International News: Spotlight on ESG, Impact & Sustainability

    INTERNATIONAL NEWS / REPORT

    International News: Spotlight on ESG, Impact & Sustainability

    May 2023

    Read time: 4 min

    Key takeaways
    Overview

    ESG is understood to be an acronym for “environmental, social and governance,” but the term can be challenging because it’s used to describe similar but distinct communities of practice, including corporate social responsibility, socially responsible investing, corporate sustainability and impact finance.

    In the 1980s, pension investor concerns for social and environmental issues evolved into what became known as socially responsible investing, which screened out investments that raised concerns over various human rights and environmental issues. This eventually spurred a corporate social responsibility (CSR) movement, pressuring corporations to take responsibility for the negative external impacts of their operations.

    A global sustainability movement also began in the 1980s seeking to reconcile economic development with the protection of social and environmental balance. This was adapted in the private sector into corporate sustainability, an intentional strategy to create long-term value through improved social and environmental impact. Corporate sustainability differs from CSR in that the latter is often not driven by strategic business imperatives.

    The investor perspective on financially material aspects of corporate sustainability coalesced under the term ESG, as famously used in a 2004 United Nations report issued by a coalition of 20 major financial institutions. The report included recommendations on integrating ESG value drivers into financial market research, analysis and investment. This was the birth of ESG, which has blossomed into an important asset class in worldwide financial markets.

    Although ESG has become politically fraught in the United States, internationally ESG regulation is becoming pervasive. This issue details these global developments, which, with the potential to more closely align business imperatives with social good, are fundamentally altering standards of corporate responsibility and investment decisions and analysis.

    In depth
    Authors

    David A. Cifrino

    Counsel

    Boston

    Dr. Philipp Grenzebach

    Partner

    Düsseldorf, Frankfurt

    Frank Müller

    Partner

    Frankfurt

    Raminta Dereskeviciute

    Partner

    London – 22 Bishopsgate

    Ludovica Rabitti

    Senior Associate

    London – 22 Bishopsgate

    Mark Fine

    Partner

    London – 22 Bishopsgate

    More Insights

  • Antitrust M&A Snapshot | Q1 2023

    Antitrust M&A Snapshot | Q1 2023

    REPORT

    Antitrust M&A Snapshot | Q1 2023

    April 20, 2023

    Read time: 2 min

    Key takeaways
    Overview

    McDermott Will & Emery’s global competition practice can assist clients with antitrust M&A issues in various jurisdictions around the world. Feel free to contact one or more of our partners in our various offices. The individuals below can assist or can refer you to one of our many other lawyers in our competition team who can help with a specific question.

    United States: Jon DubrowJoel GrosbergRay Jacobsen and Stephen Wu

    Europe: Jacques BuhartChristian KrohsHendrik Viaene, Frédéric Pradelles and Stéphane Dionnet

    In depth
    Authors

    Anthony S. Ferrara

    Partner

    Washington, DC

    Max Küttner

    Associate

    Düsseldorf

    Jon B. Dubrow

    Partner

    Washington, DC

    Joel R. Grosberg

    Partner

    Washington, DC

    Stéphane Dionnet

    Partner

    Brussels

    More Insights

  • International News: Spotlight on Life Sciences

    International News: Spotlight on Life Sciences

    INTERNATIONAL NEWS / REPORT

    International News: Spotlight on Life Sciences

    February 2023

    Read time: 3 min

    Key takeaways
    Overview

    After the post-pandemic boom enjoyed by the Life Sciences sector in 2021, the keyword going into 2023 is uncertainty. On the investment side, it’s shifted dramatically from a seller’s to a buyer’s market, and uncertainty is impacting every aspect of business, including the new transition timelines announced for the EU and UK medical device regimes, and protection of sensitive patient and commercial data owing to the stratospheric rise in cybersecurity insurance premiums.

    Never has it been more important for businesses to manage the issues that are within their control, such as ensuring robust compliance and proactively preparing for dispute resolution.

    Some extremely positive messages did, however, emerge from panel discussions at McDermott’s Health and Private Equity (HPE) Europe 2022 and European Life Sciences and Healthcare Symposium. Businesses that deliver excellence, whether that’s in patient care or with good scientific assets or an advanced product, are likely to weather the current challenges. In addition, the launch in Spring 2023 of the Unified Patent Court and the European patent with unitary effect will revolutionise the way patents are enforced in Europe, finally delivering the option to enforce, attack, and defend a patent before a single court.

    In depth
    Authors

    Robert Duffy

    Counsel

    Washington, DC

    Jana Grieb

    Partner

    Frankfurt

    Sharon Lamb

    Partner

    London – 22 Bishopsgate

    Laura McLane

    Partner

    Boston

    Dana M. McSherry

    Partner

    Boston

    Bella North

    Senior Associate

    London – 22 Bishopsgate

    Diana Pisani

    European Patent Attorney

    London – 22 Bishopsgate

    More Insights

  • Healthcare Regulatory Check-up | December 2022

    Healthcare Regulatory Check-up | December 2022

    REPORT

    Healthcare Regulatory Check-up | December 2022

    February 2023

    Read time: 2 min

    Key takeaways
    Overview

    This issue of McDermott’s Healthcare Regulatory Check-Up highlights significant regulatory activity between November 21 and December 31, 2022, including recent enforcement activity and a summary of the Office of Inspector General’s (OIG’s) Advisory Opinion Nos. 22-20 and 22-22.

    In depth
    Authors

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Monica Wallace

    Partner

    Chicago

    More Insights

  • International Legal Highlights Korea | December 2022

    International Legal Highlights Korea | December 2022

    REPORT

    International Legal Highlights Korea | December 2022

    December, 2022

    Read time: 2 min

    Key takeaways
    Overview

     

    In depth
    Authors

    Heather Cooper

    Partner

    Miami

    Carl J. Fleming

    Partner

    Washington, DC

    Philip Tingle

    Partner

    Miami

    Edward Zaelke

    Partner

    Los Angeles

    Jon B. Dubrow

    Partner

    Washington, DC

    Joel R. Grosberg

    Partner

    Washington, DC

    Raymond A. Jacobsen , Jr.

    Partner

    Washington, DC

    Stephen Wu

    Partner

    Chicago

    Christian Krohs

    Partner

    Düsseldorf, Cologne

    More Insights